Publication Name	世界华人消化杂志
手稿编号	38056
手稿来源省、自治区或特别行政区	北京市

Received	2020-12-17 00:23
Peer-Review Started	2020-12-17 00:45
To Make the First Decision
Return for Revision	2020-12-25 00:12
修回稿	2021-01-02 16:52
Second Decision	2021-01-15 09:23
期刊总编辑接受
公司总编辑接受	2021-01-18 01:34
预出版	2021-01-18 01:34
缴纳版面费
Edit the Manuscript by Language Editor
排版	2021-03-08 11:25
在线出版	2021-03-08 13:09

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化内科学
手稿栏目类型	文献综述
文章标题	维得利珠单抗治疗炎症性肠病的研究进展
手稿来源	自由来稿
所有作者列表	靳琦文, 王晓娣
基金项目及其编号
通讯作者	王晓娣, 研究生, 主任医师, 100029, 北京市朝阳区樱花园东街, 中日友好医院消化内科. XDWang60@hotmail.com
关键词	炎症性肠病; 生物制剂; 维得利珠单抗; 整合素拮抗剂; 肠道选择性
核心内容提要	维得利珠单抗作为一种人源化的整合素拮抗剂通过选择性抑制整合素ɑ4β7与黏膜地址素细胞黏附分子-1(MAdCAM-1)相互作用, 阻断淋巴细胞肠道归巢以达到治疗效果, 本文对维得利珠单抗治疗炎症性肠病的作用机制、疗效和安全性作一综述.
出版日期	2021-03-08 13:09
引文著录	靳琦文, 王晓娣. 维得利珠单抗治疗炎症性肠病的研究进展. 世界华人消化杂志 2021; 29(5): 248-255
URL	https://www.wjgnet.com/1009-3079/full/v29/i5/248.htm
DOI	https://dx.doi.org/10.11569/wcjd.v29.i5.248

Full Article (PDF)	WCJD-29-248.pdf
审稿意见	WCJD-38056-Peer-review(s).pdf
科学编辑工作清单	WCJD-38056-Scientific editor work list.pdf